Hospitals may limit the use of a new Eli Lilly’s antibody treatment that would help COVID-19 patients at risk for serious illness.
The decision comes as hospitals continue dealing with a jump in patients due to spikes in the virus, while managing a tight supply pool. This week, the United States hit 11 million confirmed cases of COVID-19. Nearly 250,000 people have died from the virus.
Stay informed.Stay ahead.
Join Washington Examiner for unlimited access to the news, analysis, and commentary that matter most.
See Options
Already a member? Log in
Already a print subscriber? Click here to login/register your account
